China has adjusted the list of drugs covered by national health insurance, including drugs related to the treatment of COVID-19, the National Healthcare Security Administration announced on Monday.

The administration has added Ribavirin, Arbidol and other drugs to the list. All the drugs used in national COVID-19 treatment have now been covered.

The new list will start to be applied on March 1, 2021.